Notices. Notice

362 words·~2 min read·/register/2012/06/25/2012-15393

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4184-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2012-N-0001] Oncologic Drugs Advisory Committee; Amendment of Notice AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration

(FDA)is announcing an amendment to the notice of meeting of the Oncologic Drugs Advisory Committee. This meeting was announced in the **Federal Register** of May 31, 2012 (77 FR 32125-32126). The amendment is being made to reflect a change in the *Date and Time,* and *Procedure* portions of the document. The *Date and Time* of the meeting will change to July 24, 2012, from 8 a.m. to 6 p.m. The *Procedure* portion of the document has changed to reflect an updated public participation time of 10:30 a.m. to 11 a.m., and 4:30 p.m. to 5 p.m. There are no other changes. FOR FURTHER INFORMATION CONTACT: Caleb Briggs, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301-796-9001, FAX: 301-847-8533, *ODAC@fda.hhs.gov,* or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), and follow the prompts to the desired center or product area. Please call the Information Line for up-to-date information on this meeting. SUPPLEMENTARY INFORMATION: In the **Federal Register** of May 31, 2012, FDA announced that a meeting of the Oncologic Drugs Advisory Committee would be held on July 24, 2012. On page 32125, in the third column, the *Date and Time* portion of the document is changed to read as follows: *Date and Time:* The meeting will be held on July 24, 2012 from 8 a.m. to 6 p.m. On page 32126, in the first column, the third sentence in the *Procedure* portion of the document is changed to read as follows: *Procedure:* Oral presentations from the public will be scheduled between approximately 10:30 a.m. to 11 a.m., and 4:30 p.m. to 5 p.m. This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees. Dated: June 20, 2012. Jill Hartzler Warner, Acting Associate Commissioner for Special Medical Programs. [FR Doc. 2012-15393 Filed 6-22-12; 8:45 am]

Connections1 off-index

1 reference not yet in our index

21 CFR 14

Citation graph

cites case law

Notices

Notice

Cite21 CFR 14

Cites 1Cited by 0 across 0 sources